ReviewAmerican journal of physiology. Heart and circulatory physiology2023

Immune interactions in pembrolizumab (PD-1 inhibitor) cancer therapy and cardiovascular complications.

Abha Banerjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.